Johnson and Johnson is their vaccine candidate.

Trial is on pause.

It seems like we're reporting some of this stuff every week.

Paws due to unexplained illness, they say.

Now this was in the statement in the article,

Johnson and Johnson said that under its guidelines,

the participants illness is being reviewed and evaluated

by the study's independent data safety monitoring board.

This is a phase three trial.

This is Johnson and Johnson subsidiary Janssen's

COVID-19 vaccine candidate.

There's really not much information.

I was expecting by airtime we would have had something.

This happened one day.

I was thinking by today, we would at least know

what the illness is, but still no word on the illness.

Yeah, no word on the illness.

And no word if the participant was even

in the vaccine trial arm or the placebo trial arm.

So we don't even have that information at this point.

Now remember, when we reported on AstraZeneca's pause

for the transverse myelitis, that was four days

...